A more comprehensive approach to the assessment and reporting of all hospital-onset bacteremia was a major topic at this year's Association for Vascular Access Scientific Meeting. We learned from Michelle DeVries, MPH, CIC, VA-BC lecture "Beyond CLABSI; Considering Hospital Onset Bacteremia," that current literature supports moving beyond just...
Innovative startup reshaping the Peripheral Intravenous Catheter (PIV) market closes seed financing round of $2.5M. DELRAY BEACH, Florida (October 27, 2020) – SkyDance Vascular (SkyDance) today announced the completion of their initial seed funding round, securing $2.5M through private investments. The startup, founded in 2017, has reimagined the P...
Live interview with Barbara DeBaun and Nancy C. Caralla from C Diff Foundation on VoiceAmerica discussing how better blood culture tests equal better patient care, fewer antibiotics, and less C.difficile. For full story click here Reposted from LinkedIn / Barbara DeBaun and Nancy C. Caralla. / October 2020.
Innovative startup reshaping the Peripheral Intravenous Catheter (PIV) market lays out current challenges and groundbreaking solution to a critical healthcare procedure. SkyDance Vascular (SkyDance), a company established to transform the market for Peripheral Intravenous Catheters (PIV), today announces the debut of a new website, www.sk...
Innovative startup to introduce a newly designed catheter looking to reduce infection rates and complications from usage. SkyDance Vascular (SkyDance), a company aiming to transform the market for Peripheral Intravenous Catheters (PIV), has engaged Thasis LLC (Thasis) to assist with its fund-raising strategy and develop the appropriate market...